2360 Technical Briefs

References 1. Ruzicka BB, Jhamandas KH. Excitatory amino acid action on the release of brain neurotransmitters and neuromodulators: biochemical studies. Prog Neurobiol 1993;40:223–47. 2. Roettger VR, Goldfinger MD. Evidence for amino acid concentration gradients between CSF and extracellular fluid. Neurosci Lett 1994;178:197– 200. 3. Olney JW. Excitatory amino acids and neuropsychiatric disorders. In: Hicks TP, Lodge D, McLennan H, eds. Excitatory amino acid transmission. Neurology and neurobiology. New York: AR Liss, 1987;24:217–24. 4. Plum CM. Free amino acids levels in the cerebrospinal fluid of normal humans and their variation in cases of epilepsy and Spielmeyer-Vogt-Batten disease. J Neurochem 1974;23:595–600. 5. Araki K, Harada M, Ueda Y. Alteration of amino acid content of cerebrospinal fluid from patients with epilepsy. Acta Neurol Scand 1988;78:473–9. 6. Pitkanen A, Matilainen R, Halonen T. Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients. J Neural Transm 1989;76: 221–30. 7. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann Neurol 1990;28:3–8. 8. Rothstein JD, Tsai G, Kuncl RW, Chaudhry V, Cornblath DR, Drachman DB, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990;28:18–25. 9. Perry TL, Krieger C, Hansen S, Eisen A. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann Neurol 1990;28:12–7. 10. Young AB. What’s the excitement about excitatory amino acids in lateral sclerosis? Ann Neurol 1990;28:9–10. 11. Spink DK, Martin DL. Excitatory amino acids in amyotrophic lateral sclerosis [Letter]. Ann Neurol 1991;29:111. 12. Donzanti BA, Yamamoto BK. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci 1988;43:913–22. 13. Fleisher GA, Wakim KG, Goldstein NG. Glutamic oxalacetic transaminase and lactic dehydrogenase in serum and cerebrospinal fluid of patients with neurologic disorders. Proc Staff Meet Mayo Clin 1957;32:188–97.